Antitumor activity and antioxidant role of Streblus asper bark against Ehrlich ascites carcinoma in Swiss albino mice. 2013

R B Suresh Kumar, and Biswakanth Kar, and Narayan Dolai, and Indrajit Karmakar, and Sagnik Haldar, and Sanjib Bhattacharya, and Pallab K Haldar
Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, West Bengal, India.

The present study assessed the methanol extract of Streblus asper stem bark (MESA) for antitumor effect and antioxidant influence against Ehrlich ascites carcinoma (EAC) in Swiss albino mice. Twenty four hours after intraperitonial inoculation of tumor (EAC) cells in mice, MESA was administered at 200 and 400 mg/kg body weight daily for 9 consecutive days. On the 10 th day, half of the mice were sacrificed for estimation of tumor parameters, haematological, liver and kidney antioxidant parameters; and the rest were kept alive for assessment of survival. MESA exhibited dose dependent and significant (p < 0.01) decrease in tumor proliferation and extended the life span of EAC bearing mice. Hematological profiles were significantly (p < 0.01) restored near to normal in MESA treated mice as compared to EAC control. MESA treatment significantly (p < 0.01) modulated the hepatic and renal antioxidant parameters as compared to EAC control. The present study demonstrated that S. asper bark possessed promising antitumor efficacy in mice, plausibly mediated by amelioration of oxidative stress by multiple mechanisms.

UI MeSH Term Description Entries
D008297 Male Males
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D002286 Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. Ehrlich Ascites Tumor,Ascites Tumor, Ehrlich,Ehrlich Tumor Carcinoma,Tumor, Ehrlich Ascites
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D024301 Plant Bark The outer layer of the woody parts of plants. Bark, Plant,Bark, Tree,Tree Bark,Barks, Plant,Barks, Tree,Plant Barks,Tree Barks
D029586 Moraceae The mulberry plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. They have milky latex and small, petalless male or female flowers. Brosimum,Castilla Plant,Cudrania,Dorstenia,Streblus,Brosimums,Castilla Plants,Cudranias,Dorstenias,Plant, Castilla,Plants, Castilla

Related Publications

R B Suresh Kumar, and Biswakanth Kar, and Narayan Dolai, and Indrajit Karmakar, and Sagnik Haldar, and Sanjib Bhattacharya, and Pallab K Haldar
August 2004, Acta pharmacologica Sinica,
R B Suresh Kumar, and Biswakanth Kar, and Narayan Dolai, and Indrajit Karmakar, and Sagnik Haldar, and Sanjib Bhattacharya, and Pallab K Haldar
February 2004, Journal of pharmacological sciences,
R B Suresh Kumar, and Biswakanth Kar, and Narayan Dolai, and Indrajit Karmakar, and Sagnik Haldar, and Sanjib Bhattacharya, and Pallab K Haldar
January 2021, Nutrition and cancer,
R B Suresh Kumar, and Biswakanth Kar, and Narayan Dolai, and Indrajit Karmakar, and Sagnik Haldar, and Sanjib Bhattacharya, and Pallab K Haldar
January 2013, Indian journal of pharmacology,
R B Suresh Kumar, and Biswakanth Kar, and Narayan Dolai, and Indrajit Karmakar, and Sagnik Haldar, and Sanjib Bhattacharya, and Pallab K Haldar
January 2015, Pharmacognosy research,
R B Suresh Kumar, and Biswakanth Kar, and Narayan Dolai, and Indrajit Karmakar, and Sagnik Haldar, and Sanjib Bhattacharya, and Pallab K Haldar
January 2012, Natural product research,
R B Suresh Kumar, and Biswakanth Kar, and Narayan Dolai, and Indrajit Karmakar, and Sagnik Haldar, and Sanjib Bhattacharya, and Pallab K Haldar
May 2010, Molecular and cellular biochemistry,
R B Suresh Kumar, and Biswakanth Kar, and Narayan Dolai, and Indrajit Karmakar, and Sagnik Haldar, and Sanjib Bhattacharya, and Pallab K Haldar
September 2017, Oncology letters,
R B Suresh Kumar, and Biswakanth Kar, and Narayan Dolai, and Indrajit Karmakar, and Sagnik Haldar, and Sanjib Bhattacharya, and Pallab K Haldar
October 2011, Asian Pacific journal of tropical medicine,
R B Suresh Kumar, and Biswakanth Kar, and Narayan Dolai, and Indrajit Karmakar, and Sagnik Haldar, and Sanjib Bhattacharya, and Pallab K Haldar
April 2007, Journal of pharmacological sciences,
Copied contents to your clipboard!